Interpreting a PYP Study for TTR Cardiac Amyloid

Where PET is Winning: Its Expanding Role in Metabolic Applications and Opportunities for Growth

Dr. Jamieson Bourque, ASNC’s President-Elect, joins Drs. Nishant Shah and Fililpe Moura for a conversation on the superb advances PET has made in recent years, and the resultant advances in diagnosis, risk stratification and patient management. Further, with the entrée of new tracers, and AI, the three discuss where further potential for new applications and enhancements to patient care may lie.

Reflecting on 2024 and Envisioning 2025 for ASNC

ASNC President Panithaya Chareonthaitawee, MD, and Immediate Past President Lawrence Phillips, MD, MASNC, share key insights about where the filed of nuclear cardiology is headed in a conversation led by Matthew Harinstein, MD, MBA, FASNC.

Expanding our Diagnostic Capabilities with CZT SPECT

In this episode featuring Dr. Ronald Schwartz, the advantages of CZT over conventional cameras are considered. Dr. Schwartz discusses how the newer technology has expanded “what we can do with perfusion, function and metabolic imaging with SPECT”.  He evaluates the exciting applications available and the practical considerations related to image acquisition and quality.

The Role of Myocardial Viability Imaging in Clinical Practice

Dr. Marcelo Di Carli, Editor-in-Chief of the Journal of Nuclear Cardiology, speaks on one of his favorite topics – Viability Imaging in Clinical Practice – in this episode.  Describing it as “the big task” for cardiac imagers, Dr. Di Carli outlines the essential concepts in myocardial viability, such as hibernation and stunning, as well as the importance of distinguishing between tissue viability and nonviability. He reviews the strengths and weaknesses of the imaging modality options for this purpose, stating that there is room for all of the techniques in providing care for cardiac patients.

Interpreting a PYP Study for TTR Cardiac Amyloid

Treatment of cardiac amyloidosis is a hot topic. Listen as ASNC Past President, Dr. Prem Soman, imparts his knowledge on interpreting studies and more.  Delving into how to use the imaging and relate it to clinical components, the discussion is packed with tips on starting a cardiac amyloidosis program and where the future may lead. Be sure to listen to the end to learn where mistakes happen and how to avoid them.